계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
Celldom, Inc
company
About
Find and study cells that make diseases incurable
- 1 - 10
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $1.50M
- Industries
- Biotechnology,Genetics,Health Care,Life Science
- Founded date
- Feb 1, 2016
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Celldom is developing next generation, high throughput single cell analysis technology to advance research, drug discovery, and drug development by illuminating diversity in cell populations. The company’s TrapTx Analyzer System uniquely integrates both phenotypic and genomic data at massive scale (up to tens of thousands of cells per experiment) to identify and characterize rare cells that play critical roles in biological pathways and disease. Celldom is developing initial applications of the platform in the areas of oncology, immunology and stem cell biology.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$1.72M
Celldom, Inc has raised a total of
$1.72M
in funding over 2 rounds. Their latest funding was raised on
Sep 1, 2018 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 1, 2018 | Grant | $1.50M | 1 | — | — | Detail |
| Jan 1, 2017 | Grant | $225K | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Celldom, Inc is funded by 1 investors.
National Institutes of Health
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
National Institutes of Health
|
— | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
